Correction: Potential role of pyridostigmine in the management of pediatric chronic intestinal pseudo-obstruction in a girl with ACTL6B mutation: a case report and a review of literature Authors: Immacolata Rulli, Angelo Mattia Carcione, Claudio Romano, Roberto Chimenz, Valeria Chirico, Lucia Marseglia, Carmelo Romeo, Eloisa Gitto Published: 2026 Boxes Wrong citation In the published article, there was a mistake in the Table 2 “Main evidences about pyridostigmine use in PIPO”. In the fourth box, “Pyridostigmine as a therapeutic option for pediatric GI dysmotilities in ATR-X syndrome” was incorrectly cited as “Boybeyi Türer et al., 2020 (7)”. The correct citation is: Article title: Pyridostigmine as a therapeutic option for pediatric gastrointestinal dysmotilities in ATR-X syndrome. Case report and literature review” Authors and year: “Comisi FF et al., 2024 (33)’’. The full citation should also be listed in References as “33. Comisi FF, Soddu C, Corpino M, Marica M, Cacace R, Foiadelli T, Savasta S. Pyridostigmine as a therapeutic option for pediatric gastrointestinal dysmotilities in ATR-X syndrome. Case report and literature review. Front Pediatr. 2024 Dec 17;12:1460658. doi: 10.3389/fped.2024.1460658. PMID: 39741769; PMCID: PMC11685138.” The original version of this article has been updated.